Main trends of immune effects triggered by nanomedicines in preclinical studies
Blanka Halamoda-Kenzaoui, Susanne Bremer-Hoffmann Directorate F-Health, Consumers and Reference Materials, European Commission Joint Research Centre (JRC), Ispra (VA), Italy Abstract: The application of nanotechnology to emerging medicinal products is a crucial parameter for the implementation of...
Guardado en:
Autores principales: | Halamoda-Kenzaoui B, Bremer-Hoffmann S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b56e46c056e4b8399a74ddb452bae6a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Nanomedicine journal
- Journal of Interdisciplinary nanomedicine
- European journal of nanomedicine
-
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
por: Giannakou C, et al.
Publicado: (2016) -
New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies
por: Giulia Mitola, et al.
Publicado: (2021)